Login / Signup

A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.

Chawalit LertbutsayanukulAnussara PrayongratDanita KannarunimitChakkapong ChakkabatBuntipa NetsawangSarin Kitpanit
Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)
SEQ and SIB provide excellent survival outcomes with few late toxicities. According to our study, SIB with a satisfactory dose-volume constraint to nearby critical organs is the technique of choice for NPC treatment due to its convenience.
Keyphrases
  • radiation therapy
  • phase iii
  • clinical trial
  • open label
  • squamous cell carcinoma
  • gene expression
  • single cell
  • dna methylation
  • phase ii
  • combination therapy